CKM

CKM encodes the muscle-specific isoenzyme of creatine kinase (CK-MM), a muscle metabolic enzyme whose expression and release are tied to muscle integrity and energy metabolism (PMID:1887884, PMID:3613854). Its mRNA is insulin-responsive: CK-M transcript levels fall markedly in diabetic rat heart and are restored toward normal by acute and chronic insulin administration (PMID:1887884). CK-MM is a metal-dependent enzyme that, upon release from injured skeletal or cardiac muscle, circulates as the tissue isoform MM3 and undergoes sequential carboxy-terminal lysine cleavage by carboxypeptidase to MM2 and then the serum isoform MM1, with the MM3/MM1 ratio rising earlier than total CK or CK-MB and providing early detection of acute myocardial infarction and reperfusion (PMID:2686906, PMID:3815799, PMID:1762189). Circulating CK-MM autoantibodies, present in all subjects tested, form immune complexes with CK-MM and modulate its clearance rate from plasma (PMID:16810680). Within muscle cells, CKM regulates skeletal muscle development, inhibiting proliferation and promoting apoptosis and differentiation of primary myoblasts (PMID:37508090). A CKM Glu83Gly coding variant (rs11559024) lowers baseline serum CK levels and CK inducibility, indicating that the amino acid sequence affects constitutive enzyme levels or release (PMID:28790154). Beyond these findings, the catalytic mechanism, structure, and protein partners of CK-MM have not been characterized in the available corpus.

1. 1987 Medium

   Established that CK-MM accumulation is a specific defect in muscular dystrophy and that CK-MM subtype profiling can report on muscle pathology earlier than existing markers, motivating CK-MM as both a disease readout and a clinical tool.

   Evidence Innervated contracting DMD muscle fiber cultures with isozyme activity assays; serial AMI blood sampling with anion-exchange HPLC and electrophoresis for MM subtypes

   PMID:3613854 PMID:3815799

   Open questions at the time

   • Mechanism by which CK-MM accumulation is selectively impaired in DMD not defined
   • No molecular explanation for the basis of MM3/MM1 conversion kinetics
2. 1988 Medium

   Showed that exercise-induced plasma CK is predominantly the muscle MM isoform with sex-linked differences in leakage, linking serum CK levels directly to skeletal muscle release dynamics.

   Evidence Treadmill exercise in male and female rats with plasma and tissue CK isoenzyme profiling, CK-BB as internal control

   PMID:3174399

   Open questions at the time

   • Molecular basis of sex difference in CK-MM leakage not established
   • Does not address membrane mechanism of release from muscle
3. 1989 Medium

   Defined the post-translational processing pathway of circulating CK-MM (MM3→MM2→MM1 via carboxypeptidase) and its kinetic value for early AMI and reperfusion diagnosis.

   Evidence Serial AMI patient sampling with anion-exchange chromatography and high-voltage electrophoresis, reperfused vs non-reperfused comparison

   PMID:2686906

   Open questions at the time

   • Identity and regulation of the responsible carboxypeptidase not pinned down here
   • Tissue vs circulating processing rates not separated mechanistically
4. 1991 Medium

   Demonstrated CK-M mRNA is insulin-responsive, connecting CKM expression to metabolic/hormonal control in heart, and ruled out a CKM coding defect as a cause of myotonic dystrophy.

   Evidence Northern blot quantitation in streptozotocin-diabetic rat hearts with insulin treatment; cDNA sequencing from a DM patient; monoclonal antibody immunoinhibition with EDTA/heat lability tests

   PMID:1762189 PMID:1887884 PMID:2016086

   Open questions at the time

   • Transcriptional mechanism of insulin responsiveness not defined
   • Metal-dependence of the tissue isoform only partially characterized
5. 1995 Low

   Linked a CK-MM coding point mutation (codon 54 Asp→Gly) to CK-MM protein deficiency, providing first genetic evidence that CKM sequence variation controls enzyme presence.

   Evidence Single AMI patient case with serum/tissue CK-MM immunoassay and cDNA/genomic DNA sequencing

   PMID:7884961

   Open questions at the time

   • Single case with no functional validation of the point mutation
   • Causal link between mutation and protein deficiency not established by reconstitution
6. 2006 Medium

   Identified CK-MM autoantibodies as a universal modulator of CK-MM clearance, explaining inter-individual variability in circulating CK levels independent of muscle release.

   Evidence ELISA in 25 subjects, protein A-sepharose immune complex isolation, and in vivo mouse bolus CK injection with antibody administration

   PMID:16810680

   Open questions at the time

   • Mechanism of antibody-mediated clearance (Fc receptor, organ site) not defined
   • Physiological/pathological relevance of autoantibody levels not established
7. 2017 Low

   Showed a common CKM coding variant (Glu83Gly) lowers baseline serum CK and its inducibility, tying genotype to constitutive enzyme level/release without a myalgia phenotype.

   Evidence Meta-analysis of GoDARTS cohort and JUPITER trial for genetic association with baseline CK, CK SD, and myalgia

   PMID:28790154

   Open questions at the time

   • Genetic association without a direct biochemical mechanism experiment
   • Whether the variant alters enzyme stability, activity, or release is unresolved
8. 2023 Low

   Provided functional evidence that CKM regulates myogenic cell fate, inhibiting proliferation and promoting differentiation, extending its role beyond a passive metabolic enzyme.

   Evidence Overexpression and RNAi in chicken primary myoblasts with proliferation/apoptosis/differentiation assays and transcriptome sequencing

   PMID:37508090

   Open questions at the time

   • Chicken model only, not confirmed in mammalian muscle
   • Molecular pathway linking CKM to myogenic gene expression not defined

• The catalytic mechanism, three-dimensional structure, direct protein partners, and the molecular basis by which CKM influences myoblast differentiation remain uncharacterized in the available corpus.
• No structural model of CK-MM in the timeline
• No identified direct physical partners
• Mechanism connecting enzyme function to muscle development unknown